Aripiprazole versus brexpiprazole for people with schizophrenia
No Thumbnail Available
Date
2023
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Description
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
To assess the efficacy and tolerability of aripiprazole compared to brexpiprazole in people diagnosed with schizophrenia or schizophrenia‐like psychosis.
